Role of artificial intelligence in detecting cervical cancer
Not Applicable
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2021/03/032299
- Lead Sponsor
- Ayesha Siddiqua
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Women between 30- 65 years who are
Subjected to routine cervical screening
2.Includes those scheduled for colposcopic evaluation for indications-
-Positive Pap test (ASCUS/ASC-H/LSIL/HSIL/Invasive -carcinoma (Bethesda classification)
-HR-HPV positive
-Clinically suspicious cervix
Exclusion Criteria
1.Obvious growth on cervix (Ca cervix)
2.Unmarried woman
3.Pregnant/ postpartum
4.Menstruating on the day of the visit
5.Genital prolapse grade 2 and beyond
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Comparison of VIA â??AI using ECO device with colposcopy diagnosis in identification of cervical epithelial abnormalities for screen positive women <br/ ><br>2.Comparison of VIA â??AI using ECO device with histopathology reports <br/ ><br>3.Comparison of VIA â??AI using ECO device with screen test (Pap smear/ HPV) results <br/ ><br>Timepoint: 4 WEEKS
- Secondary Outcome Measures
Name Time Method 1.Analysis of sensitivity,specifivity of VIA-AI using ECO device with standard screening procedures of carcinoma cervixTimepoint: 1 YEAR